Global AI In Vitro Diagnostic Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global AI In Vitro Diagnostic Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global AI In Vitro Diagnostic market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The global market for in vitro diagnostics (IVD) was growing steadily and was expected to continue its growth in the coming years.

Market Overview: The in vitro diagnostics market involves medical devices, instruments, and reagents used for diagnostic testing of samples such as blood, urine, tissue, and other bodily fluids. AI in vitro diagnostics refers to the integration of artificial intelligence and machine learning technologies into these diagnostic tools and processes.

Growth Drivers: The market for AI in vitro diagnostics has been driven by factors such as increasing demand for personalized medicine, rising prevalence of chronic and infectious diseases, technological advancements in diagnostics, and the need for efficient and accurate diagnostic solutions.

Application Areas: AI has found applications in various areas of in vitro diagnostics, including clinical chemistry, immunoassays, microbiology, hematology, genetic testing, and molecular diagnostics. AI algorithms can aid in data analysis, interpretation, and decision-making, improving the accuracy and efficiency of diagnostic procedures.

This report is a detailed and comprehensive analysis for global AI In Vitro Diagnostic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global AI In Vitro Diagnostic market size and forecasts, in consumption value ($ Million), 2018-2029

Global AI In Vitro Diagnostic market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global AI In Vitro Diagnostic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global AI In Vitro Diagnostic market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for AI In Vitro Diagnostic

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global AI In Vitro Diagnostic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Renalytix, Seegene, Sysmex, PathAI and Prognos, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

AI In Vitro Diagnostic market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Next-Generation Sequencing Technology
PCR Technology
Chemistry and IA Technology
Pathology Technology

Market segment by Application
Cancer Diagnostics
Infectious Disease Testing
Metabolic Testing
Cardiac Testing
Diabetes Testing

Market segment by players, this report covers
Renalytix
Seegene
Sysmex
PathAI
Prognos
Qiagen
CloudMedX Health
Deepcell
Digital Diagnostics
EKF Diagnostics Holdings
Freenome
GE Healthcare
Glooko
Adaptive Biotechnologies
Aidoc
Anumana
ARUP Laboratories
K Health
Lunit

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe AI In Vitro Diagnostic product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of AI In Vitro Diagnostic, with revenue, gross margin and global market share of AI In Vitro Diagnostic from 2018 to 2023.

Chapter 3, the AI In Vitro Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI In Vitro Diagnostic market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of AI In Vitro Diagnostic.

Chapter 13, to describe AI In Vitro Diagnostic research findings and conclusion.